Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Altria Groups Quarterly Earnings Report and Stock Performance

Elaine Mendonca by Elaine Mendonca
January 31, 2024
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On January 31, 2024, Altria Group (NYSE:MO) announced that it will be releasing its quarterly earnings report on February 1, 2024. Analysts have estimated that the company will report an earnings per share (EPS) of $1.08 for the quarter.

Looking back at the previous quarter, Altria Group managed to surpass the EPS estimate by $0.06, resulting in a 0.1% increase in the share price the following day. This demonstrates how the company’s performance can have a direct impact on its stock price.

It is important to consider that the stock price can be influenced not only by the earnings report, but also by the company’s guidance or forecast for the future. This means that even if Altria Group beats or misses the earnings estimate, the stock price can still be significantly affected.

To gain a better understanding of Altria Group’s historical earnings performance and the resulting price changes, let’s take a look at the data from the past four quarters:

– Q3 2023: EPS of 1.28, resulting in a 0.1% increase in the share price.
– Q2 2023: EPS of 1.31, leading to a 1.35% decrease in the share price.
– Q1 2023: EPS of 1.18, resulting in a 0.68% increase in the share price.
– Q4 2022: EPS of 1.18, leading to a 1.2% decrease in the share price.

As of January 30, 2024, Altria Group’s shares were trading at $40.46, reflecting a 13.56% decrease over the last 52 weeks. This negative trend in returns may lead long-term shareholders to have a bearish outlook leading up to this upcoming earnings release.

Considering Altria Group’s earnings history and the estimates provided by analysts, it is possible to gain additional insights into the company’s performance and future outlook.

MO Stock Declines Near 52-Week Low and Below 200-Day Moving Average: Potential Selling Signals for Investors

On January 31, 2024, MO stock experienced a decline in its performance, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock opened at $40.55, which was $0.09 higher than its previous close. The price of MO shares decreased by $0.12 since the market last closed, representing a drop of 0.30%. Trading near the bottom of its 52-week range suggests that MO stock has been experiencing downward pressure and struggling to gain positive momentum. Furthermore, trading below its 200-day simple moving average indicates a longer-term downward trend for MO stock. Investors and traders who closely follow technical analysis may view these indicators as potential selling signals. However, it is important to note that stock performance is influenced by various factors, including market conditions, company news, and industry trends. Therefore, it is crucial for investors to conduct thorough research and consider all relevant information before making any investment decisions.

MO Stock Performance on January 31, 2024: Revenue Holds Steady, Net Income Soars, and EPS Remains Flat – A Mixed Bag of Results for MO Stock

MO Stock Performance on January 31, 2024: Revenue Holds Steady, Net Income Soars, and EPS Remains Flat

On January 31, 2024, MO stock showed a mixed performance, with revenue holding steady, net income soaring, and earnings per share remaining flat.

Total revenue for MO stood at $20.69 billion over the past year, which indicates that the company’s revenue remained flat compared to the previous year. Similarly, the total revenue for the third quarter of 2023 was reported to be $5.28 billion, showing no change from the previous quarter.

However, despite the stagnant revenue growth, MO experienced a significant increase in net income. Over the past year, the company’s net income reached $5.75 billion, reflecting a remarkable 133.4% increase compared to the previous year. On the other hand, the net income for the third quarter of 2023 remained flat at $2.16 billion, showing no change from the previous quarter.

Furthermore, MO’s earnings per share (EPS) also witnessed a substantial increase. The EPS for the past year reached $3.19, reflecting a remarkable 138.7% increase compared to the previous year. However, similar to net income, the EPS for the third quarter of 2023 remained flat at $1.22, showing no change from the previous quarter.

These financial figures indicate that MO has been able to maintain a steady revenue stream over the past year and quarter. However, the company’s net income and EPS have experienced significant growth over the same period, showcasing the company’s ability to increase profitability and generate higher returns for its shareholders.

It is worth noting that while the revenue growth has remained stagnant, MO’s ability to increase net income and EPS suggests that the company has implemented effective cost-cutting measures and improved operational efficiencies. These factors have contributed to the company’s ability to generate higher profits despite the flat revenue growth.

Investors and analysts will closely monitor MO’s future financial reports to assess whether the company can sustain its impressive net income growth and improve revenue performance. While the flat revenue growth may be a cause for concern, the significant increase in net income and EPS demonstrate MO’s potential for long-term profitability and value creation.

Overall, MO’s stock performance on January 31, 2024, showcased a mixed bag of results. While revenue held steady, net income soared, and earnings per share remained flat. These financial indicators highlight MO’s ability to drive profitability even in the face of stagnant revenue growth, making it an intriguing stock to watch in the coming months.

Tags: MO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

Vanda Pharmaceuticals Receives FDA Approval for Investigational New Drug VTR297

Technology Artificial intelligence Market Capitalization

Connexa Sports Technologies Inc Meets Nasdaq Shareholder Equity Rule and Attracts International Investors

Recommended

Home Construction Trading online

PulteGroup Reports Positive Earnings Surprise in Q4 2022

2 years ago
Lam Research Stock

Semiconductor Sector Sees New Leveraged ETF Targeting Lam Research

2 months ago
Orion Office REIT Stock

Defying Sector Headwinds: Orion Office REIT’s Remarkable Ascent

1 month ago
Finance_Commercial (2)

Embecta Corps Positive Financial Results Overshadowed by Disappointing Guidance

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Precision BioSciences Stock Surges on Gene-Editing Breakthroughs

Hydrogen Sector’s Crossroads: Nel ASA Navigates Industry Retreat and Government Push

Norwegian Car Carrier Faces Mounting Headwinds as Shares Slide

Defense Stock Paradox: Record Orders Trigger Share Price Retreat

Idorsia Secures Strong Investor Backing in Oversubscribed Share Offering

Vulcan Energy Shares Face Pressure Following Shareholder Approval

Trending

Ebix Stock
Blockchain

Ebix Pursues Dual-Pronged Growth Strategy

by Robert Sasse
October 12, 2025
0

Ebix has launched two significant strategic moves that demonstrate the company's focused approach to strengthening its market...

India Globalization Capital Stock

Shareholder Confidence Boosts IGC Pharma’s Alzheimer’s Research

October 12, 2025
Allovir Inc Stock

Allovir’s Corporate Metamorphosis: A New Beginning as Kalaris Therapeutics

October 12, 2025
Precision BioSciences Inc Stock

Precision BioSciences Stock Surges on Gene-Editing Breakthroughs

October 12, 2025
Nel ASA Stock

Hydrogen Sector’s Crossroads: Nel ASA Navigates Industry Retreat and Government Push

October 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ebix Pursues Dual-Pronged Growth Strategy
  • Shareholder Confidence Boosts IGC Pharma’s Alzheimer’s Research
  • Allovir’s Corporate Metamorphosis: A New Beginning as Kalaris Therapeutics

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com